Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT)
Abstract
The overarching goal of the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program was to increase our ability to rapidly respond to a disease or threat and improve individual readiness and total force health protection by providing centralized laboratory capabilities at non-tertiary care settings. ADEPT focused on the development of Ribonucleic Acid (RNA)-based vaccines, potentially eliminating the time and labor required for traditional manufacture of a vaccine while at the same time improving efficacy. Additionally, ADEPT developed methods to transiently deliver nucleic acids for vaccines and therapeutics, and kinetically control the timing and levels of gene expression so that these drugs will be safe and effective for use in healthy subjects. ADEPT also focused on advanced development of key elements for simple-to-operate diagnostic devices.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2020
- Source ID
- ded1b8f3febbcfc4d50b25c9437f737d
Related Documents
- Root: BIOMEDICAL TECHNOLOGY